Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897250232> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2897250232 endingPage "S955" @default.
- W2897250232 startingPage "S954" @default.
- W2897250232 abstract "MET exon 14 skipping (METex14), or splice site, mutations result in the deletion of the juxtamembrane domain of MET, leading to increased MET receptor pathway signaling. Non-small cell lung cancer (NSCLC) patients with METex14 mutations are eligible for therapy with MET inhibitors like crizotinib. METex14 mutations are diverse and complex and can be challenging to detect by targeted DNA NGS assays alone. The Archer FusionPlexTM Solid Tumor panel use anchored multiplex PCR chemistry to detect fusions and other mutations including oncogenic isoforms in 53 genes associated with solid tumors. In July 2016, we implemented the FusionPlex panel in our clinical laboratory for routine testing of NSCLC. RNA is extracted from FFPE tissue using the AllPrep DNA/RNA FFPE Kit and RNA quantity is assessed using the Qubit HS RNA Assay, and RNA quality is assessed using the PreSeq RNA QC Kit. cDNA synthesis and library preparation are performed according to the manufacturer’s recommendations. Libraries are quantified using the KAPA Library Quantification Kit, diluted to 4 nM, pooled and sequenced on the Illumina MiSeq System. Data analysis is performed using the Archer Analysis platform (v4.0.11). MET exon 14 isoforms were confirmed by an orthogonal method (DNA NGS assay and/or melt curve analysis). Since July 2016, samples from 275 NSCLC patients were successfully sequenced. Six (2.2%) MET oncogenic isoforms, consistent with MET exon 14 skipping mutations, were identified and subsequently confirmed. All six patients were female with an age range of 61-82 years. Two presented with stage I disease, two stage II, one stage III and one stage IV. To date, none of the patients have been treated with MET inhibitor therapy. The FusionPlexTM Solid Tumor NGS panel can be routinely performed in the clinical laboratory to optimize detection of MET exon 14 mutations as well as other clinically actionable gene fusions." @default.
- W2897250232 created "2018-10-26" @default.
- W2897250232 creator A5025946792 @default.
- W2897250232 creator A5029371578 @default.
- W2897250232 creator A5031645313 @default.
- W2897250232 creator A5040432994 @default.
- W2897250232 creator A5069518456 @default.
- W2897250232 creator A5073399781 @default.
- W2897250232 date "2018-10-01" @default.
- W2897250232 modified "2023-10-07" @default.
- W2897250232 title "P3.09-18 Identification of MET exon 14 Skipping Mutations by FusionPlexTM Solid Tumor Panel" @default.
- W2897250232 doi "https://doi.org/10.1016/j.jtho.2018.08.1787" @default.
- W2897250232 hasPublicationYear "2018" @default.
- W2897250232 type Work @default.
- W2897250232 sameAs 2897250232 @default.
- W2897250232 citedByCount "0" @default.
- W2897250232 crossrefType "journal-article" @default.
- W2897250232 hasAuthorship W2897250232A5025946792 @default.
- W2897250232 hasAuthorship W2897250232A5029371578 @default.
- W2897250232 hasAuthorship W2897250232A5031645313 @default.
- W2897250232 hasAuthorship W2897250232A5040432994 @default.
- W2897250232 hasAuthorship W2897250232A5069518456 @default.
- W2897250232 hasAuthorship W2897250232A5073399781 @default.
- W2897250232 hasBestOaLocation W28972502321 @default.
- W2897250232 hasConcept C104317684 @default.
- W2897250232 hasConcept C143998085 @default.
- W2897250232 hasConcept C153911025 @default.
- W2897250232 hasConcept C194583182 @default.
- W2897250232 hasConcept C2776232967 @default.
- W2897250232 hasConcept C2776256026 @default.
- W2897250232 hasConcept C2778776201 @default.
- W2897250232 hasConcept C2779422266 @default.
- W2897250232 hasConcept C2781188995 @default.
- W2897250232 hasConcept C36823959 @default.
- W2897250232 hasConcept C501734568 @default.
- W2897250232 hasConcept C502942594 @default.
- W2897250232 hasConcept C54355233 @default.
- W2897250232 hasConcept C67705224 @default.
- W2897250232 hasConcept C71924100 @default.
- W2897250232 hasConcept C86803240 @default.
- W2897250232 hasConceptScore W2897250232C104317684 @default.
- W2897250232 hasConceptScore W2897250232C143998085 @default.
- W2897250232 hasConceptScore W2897250232C153911025 @default.
- W2897250232 hasConceptScore W2897250232C194583182 @default.
- W2897250232 hasConceptScore W2897250232C2776232967 @default.
- W2897250232 hasConceptScore W2897250232C2776256026 @default.
- W2897250232 hasConceptScore W2897250232C2778776201 @default.
- W2897250232 hasConceptScore W2897250232C2779422266 @default.
- W2897250232 hasConceptScore W2897250232C2781188995 @default.
- W2897250232 hasConceptScore W2897250232C36823959 @default.
- W2897250232 hasConceptScore W2897250232C501734568 @default.
- W2897250232 hasConceptScore W2897250232C502942594 @default.
- W2897250232 hasConceptScore W2897250232C54355233 @default.
- W2897250232 hasConceptScore W2897250232C67705224 @default.
- W2897250232 hasConceptScore W2897250232C71924100 @default.
- W2897250232 hasConceptScore W2897250232C86803240 @default.
- W2897250232 hasIssue "10" @default.
- W2897250232 hasLocation W28972502321 @default.
- W2897250232 hasOpenAccess W2897250232 @default.
- W2897250232 hasPrimaryLocation W28972502321 @default.
- W2897250232 hasRelatedWork W2054798545 @default.
- W2897250232 hasRelatedWork W2060169551 @default.
- W2897250232 hasRelatedWork W2068588654 @default.
- W2897250232 hasRelatedWork W2166888823 @default.
- W2897250232 hasRelatedWork W2169624569 @default.
- W2897250232 hasRelatedWork W2212364724 @default.
- W2897250232 hasRelatedWork W2303903837 @default.
- W2897250232 hasRelatedWork W2384774992 @default.
- W2897250232 hasRelatedWork W2417766600 @default.
- W2897250232 hasRelatedWork W4243483160 @default.
- W2897250232 hasVolume "13" @default.
- W2897250232 isParatext "false" @default.
- W2897250232 isRetracted "false" @default.
- W2897250232 magId "2897250232" @default.
- W2897250232 workType "article" @default.